Nuflor Injectable Solution, 300mg

Supplied By: Merck (065558)


SKU
012093


Unit of
Measure 500mL


Pack
Type Vial


Case
Qty 6

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023
{{purchaseHistoryItem}}


SKU 012093


Size 500mL

Case
Qty 6

Purchase History

May- 2024 {{productPurchaseHistory['012093'][0]}} Oct- 2023 {{productPurchaseHistory['012093'][0+7]}}
Apr- 2024 {{productPurchaseHistory['012093'][1]}} Sep- 2023 {{productPurchaseHistory['012093'][1+7]}}
Mar- 2024 {{productPurchaseHistory['012093'][2]}} Aug- 2023 {{productPurchaseHistory['012093'][2+7]}}
Feb- 2024 {{productPurchaseHistory['012093'][3]}} Jul- 2023 {{productPurchaseHistory['012093'][3+7]}}
Jan- 2024 {{productPurchaseHistory['012093'][4]}} Jun- 2023 {{productPurchaseHistory['012093'][4+7]}}
Dec- 2023 {{productPurchaseHistory['012093'][5]}} May- 2023 {{productPurchaseHistory['012093'][5+7]}}
Nov- 2023 {{productPurchaseHistory['012093'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

NUFLOR (florfenicol) is an injectable antibiotic indicated for treatment of bovine respiratory disease (BRD) (with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni), bovine interdigital phlegmon (with Fusobacterium necrophorum and Bacteroides melaninogenicus) in cattle.

Features & Benefits

  • Kills two major bacteria that cause BRD: Mannheimia haemolytica and Histophilus somni
  • Begins killing bacteria within 30 minutes and eliminates 99.9% of those bacteria within 24 hours
  • Continues to kill for 68 hours and remains inhibitory through 96 hours
  • Inhibits the third major bacterial cause of BRD: Pasteurella multocida
  • Effective, versatile, broad spectrum therapy in the hospital and on arrival of cattle at risk of developing BRD
  • Lowers risk with high-risk cattle – treat on arrival
  • Fewer repulls and retreatments